First Time Loading...

Kobayashi Pharmaceutical Co Ltd
TSE:4967

Watchlist Manager
Kobayashi Pharmaceutical Co Ltd Logo
Kobayashi Pharmaceutical Co Ltd
TSE:4967
Watchlist
Price: 5 304 JPY -0.86% Market Closed
Updated: May 8, 2024

Kobayashi Pharmaceutical Co Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Kobayashi Pharmaceutical Co Ltd
Revenue Peer Comparison

Comparables:
4911
4527
4927
4452
F
4921

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Kobayashi Pharmaceutical Co Ltd
TSE:4967
Revenue
¥173.5B
CAGR 3-Years
5%
CAGR 5-Years
1%
CAGR 10-Years
4%
Shiseido Co Ltd
TSE:4911
Revenue
¥973B
CAGR 3-Years
2%
CAGR 5-Years
-2%
CAGR 10-Years
3%
Rohto Pharmaceutical Co Ltd
TSE:4527
Revenue
¥263.6B
CAGR 3-Years
14%
CAGR 5-Years
8%
CAGR 10-Years
7%
Pola Orbis Holdings Inc
TSE:4927
Revenue
¥173.3B
CAGR 3-Years
-1%
CAGR 5-Years
-7%
CAGR 10-Years
-1%
Kao Corp
TSE:4452
Revenue
¥1.5T
CAGR 3-Years
4%
CAGR 5-Years
0%
CAGR 10-Years
2%
F
Fancl Corp
TSE:4921
Revenue
¥108.1B
CAGR 3-Years
-2%
CAGR 5-Years
-2%
CAGR 10-Years
3%

See Also

What is Kobayashi Pharmaceutical Co Ltd's Revenue?
Revenue
173.5B JPY

Based on the financial report for Dec 31, 2023, Kobayashi Pharmaceutical Co Ltd's Revenue amounts to 173.5B JPY.

What is Kobayashi Pharmaceutical Co Ltd's Revenue growth rate?
Revenue CAGR 10Y
4%

Over the last year, the Revenue growth was 4%. The average annual Revenue growth rates for Kobayashi Pharmaceutical Co Ltd have been 5% over the past three years , 1% over the past five years , and 4% over the past ten years .